Paige AI, Inc.

Leo Grady, the former CEO of Paige AI – developers of the first AI-based histology software to be granted approval by the US Food and Drug Administration – has turned his attention to the gut health

Paige AI , developer of artificial intelligence-based software capable of deriving cancer biomarkers from pathology images, has signed a collaboration agreement with Microsoft . The two will work tog

Large pharmaceutical companies are eager to talk about their digital transformation and their whole-hearted adoption of computational biology and artificial intelligence (AI). In the same vein, many a

As we discussed in Part 1 of this article, pharma is deriving value from applications of digital pathology across the spectrum of drug discovery and development. However, despite its promise, provider